24.04.2012
- A new biotech corn developed by Dow AgroSciences could answer the prayers of U.S. farmers plagued by a fierce epidemic of super-weeds. Or it could trigger a flood of dangerous...
23.04.2012
- AstraZeneca has agreed to buy U.S. company Ardea Biosciences for $1.26 billion, giving it a new gout drug to bolster its weak pipeline in a deal that feeds a wave of M&A in the...
23.04.2012
- Australian flu drug maker Biota Holdings has agreed to take over U.S. firm Nabi Biopharmaceuticals to create a $258 million group and move to the United States, where investors...
19.04.2012
- Europe's largest biotech company Actelion said it expects results of a key late-stage trial on heart and lung disease drug macitentan in the next few weeks after a strong Swiss...
17.04.2012
- Biotechnology - The concept of ‘White Biotech' is nothing new. People have been using natural products to create health-giving products for millennia. However in the first half of...
17.04.2012
- Seeking Effective Ingredients - Active ingredients in personal care formulations also activate sales. Consumers desire to see visible results and have raised expectations for...
15.04.2012
- Merck Serono, the biopharmaceutical division of German drugs and chemicals group Merck KGaA, inaugurated on Sunday a biotech incubator at Inter-Lab, its research and development...
13.04.2012
- Biasca, the Swiss-based APIs (Active Pharmaceutical Ingredients) and HPAPIs (Highly Potent Active Pharmaceutical Ingredients) contract manufacturing company of the Helsinn Group...
13.04.2012
- Europe's drugs watchdog is to evaluate a copycat version of the best-selling biotech drug Remicade, used to treat arthritis, in a move that underscores how the market for so-called...
05.04.2012
- A new batch of counterfeit cancer drug Avastin discovered in the United States was bought in Turkey and shipped through Britain by a UK-based business, officials said on Wednesday...
